[
sinovac
]China's Covid-19 vaccine sales drop as nations switch to mRNA shots
The efficacy of China’s inactivated vaccines ranges from about 50% to 80% in clinical trials. But they are less potent than mRNA vaccines and questions are mounting about their effectiveness against the highly transmissible delta variant.
Published on Sep 30, 2021 07:40 AM IST
Bloomberg |
Lead Sinovac scientist dies of suspected Covid as Indonesia mulls booster shot
- The death of a leading Indonesian scientist has added questions to the efficacy of the Sinovac vaccine which has been widely used in the fourth-most populous nation.
Published on Jul 08, 2021 04:48 PM IST
hindustantimes.com | Edited by Kunal Gaurav, Hindustan Times, New Delhi
Singapore latest to cast doubt over Chinese Sinovac efficacy. Here’s why
- Singapore has included only Pfizer and Moderna vaccines in its national vaccination program but has allowed private health clinics to administer Sinovac.
Updated on Jun 20, 2021 09:15 PM IST
hindustantimes.com | Edited by Kunal Gaurav, Hindustan Times, New Delhi
WHO expects to review Chinese Covid-19 vaccines on April 26: Official
WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility.
Updated on Apr 09, 2021 07:48 PM IST
Reuters | , Geneva
Sinovac says its vaccine is safe for children as young as 3
More than 70 million shots of Sinovac’s vaccine have been given worldwide, including in China.
Published on Mar 23, 2021 01:17 PM IST
AP |
Hong Kong to vaccinate teachers, cab drivers despite reports of adverse events
At least two people have died and several fallen seriously ill after receiving a vaccination by China's Sinovac.
Updated on Mar 08, 2021 02:35 PM IST
Reuters | , Hong Kong
Thailand starts Covid-19 vaccination campaign with China's Sinovac vaccines
Prime Minister Prayuth Chan-ocha, 66, attended the event, although his age falls outside the range of 18 to 59 suitable to receive SinoVac's CoronaVac vaccine, so he did not get it.
Published on Feb 28, 2021 08:43 AM IST
Reuters | , Bangkok
Chinese Covid-19 vaccine Sinovac gets local emergency use in Thailand
Thailand’s Food and Drug Administration has approved Sinovac Biotech Ltd.’s Covid-19 vaccine for local emergency use ahead of the launch of a national inoculation program.
Updated on Feb 23, 2021 12:59 PM IST
Bloomberg |
Covid-19 vaccination: Second pan-India dry run today, Chinese vaccine found 78% effective in Brazil
Immunisation drives against Covid-19 are currently underway in several countries. Vaccines developed by Pfizer-BioNTech SE and Moderna are being most widely used.
Updated on Jan 08, 2021 09:26 AM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Karan Manral
Thailand to get 2 million doses of China’s Sinovac Covid-19 vaccine
The country will receive the vaccine in three batches, with the first 200,000 doses arriving in February, 800,000 in March, and another 1 million in April, according to its health ministry.
Updated on Jan 04, 2021 10:34 AM IST
Bloomberg | Posted by Karan Manral
Covid-19 vaccine updates: India likely to decide on first vaccine this week, South Korea seeks Moderna’s candidate
On Monday, the United States and Mexico commenced phase 3 trials of the vaccine candidate of Novovax, an American biotech firm.
Updated on Dec 29, 2020 09:32 AM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Karan Manral
Sinovac vaccine shot’s efficacy uncertain despite Brazil, Turkey results
Sinovac is finalizing results of phase III trials carried out in Brazil, Turkey, Indonesia and Chile, according to a person familiar with the trials.
Published on Dec 25, 2020 03:01 PM IST
Bloomberg| Posted by Mallika Soni
Brazil scientists say Sinovac vaccine CoronaVac has proven effective in late-stage trials: Report
Brazil is the first country to complete late-stage trials of CoronaVac, which is also being tested in Indonesia and Turkey.
Updated on Dec 22, 2020 01:31 PM IST
Sao Paolo/Rio De Janeiro | Reuters | Posted by Shankhyaneel Sarkar
Covid-19 vaccine update: Serum Institute of India seeks emergency use approval for Covishield, Sputnik V phase 2 trials begin in Pune
On Sunday, Indonesia received 1.2 million doses of the vaccine candidate of China’s Sinovac. The first shot of Pfizer’s vaccine, meanwhile, is likely to be administered to people in the United Kingdom on Tuesday.
Updated on Dec 07, 2020 08:17 AM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Karan Manral
China’s Sinovac secures $500 million in funding for Covid-19 vaccine development
In a statement on its website, the company said it expects to be able to manufacture 300 million vaccine doses annually, and that it aims to complete construction of a second production facility by the end of 2020 to increase annual Covid-19 vaccine production capacity to 600 million doses.
Updated on Dec 07, 2020 06:23 AM IST
Shanghai | Reuters| Posted by Susmita Pakrasi
1.2 million doses of China-made Covid-19 vaccine arrives in Indonesia
President Joko Widodo said in a televised address that another 1.8 million doses of the vaccine are expected to arrive in early January.
Published on Dec 06, 2020 09:39 PM IST
Associated Press | Associated Press | Posted by Shankhyaneel Sarkar
Brazil’s Sau Paulo could roll out China’s Covid-19 vaccine without approval
Sau Paulo governor Joao Doria in an interview on Thursday said Sinovac could be rolled out without approval from the national health regulator, in comments described by health experts as ‘empty threat.’
Updated on Nov 27, 2020 07:58 AM IST
Sau Paulo | Reuters | Posted by Karan Manral
China vaccine trial halted in Brazil after serious adverse event
Serious adverse events that occur in drug trials include death, immediate risk of death, long term or serious incapacitation, and hospitalization.
Updated on Nov 10, 2020 01:38 PM IST
Bloomberg | Posted by Srivatsan K C
China’s Sinovac vaccine is safe, Brazil institute says
The result is only preliminary and researchers will keep monitoring the participants in the on-going trial, Covas said. It’s the first set of results of Sinovac’s Phase 3 global trials, which are also being conducted in Turkey and Indonesia.
Updated on Oct 20, 2020 09:38 AM IST
Beijing/Sao Paolo | Reuters | Posted by Shankhyaneel Sarkar
China rapidly expands use of experimental COVID-19 vaccines
The city of Jiaxing, south of Shanghai, is offering a vaccine under development by Sinovac, it said in an announcement Thursday.
Updated on Oct 16, 2020 04:53 PM IST
Taipei | Associated Press | Posted by Srivatsan K C
China’s Jiaxin to sell Sinovac’s Covid-19 vaccine for $60 in cases of emergency
Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency inoculation programme launched in July.
Updated on Oct 16, 2020 02:16 PM IST
Beijing | Reuters | Posted by Shankhyaneel Sarkar
China’s Sinovac to test Covid-19 vaccine candidate in kids, teens. Know more
According to a registration record published on Wednesday, 552 healthy participants aged between three and 17 will take two doses of US-listed Sinovac’s CoronaVac or a placebo in a combined Phase 1 and Phase 2 trial estimated to begin on September 28 in the northern Chinese province of Hebei.
Updated on Sep 18, 2020 11:58 AM IST
Hindustan Times, New Delhi | hindustantimes.com | Edited by Meenakshi Ray
China’s Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly
Health officials have been concerned about whether experimental vaccines could safely protect the elderly, whose immune systems usually react less robustly to vaccines, against the virus that has led to nearly 890,000 deaths worldwide.
Updated on Sep 08, 2020 07:25 AM IST
Beijing, China | Reuters | Posted by Shivani Kumar
Indonesia kicks off third phase of Sinovac’s Covid-19 vaccine testing
Indonesia began the third phase of a Covid-19 vaccine trial made by China’s Sinovac Biotech Ltd. with a target to begin commercial production in six months.
Updated on Aug 11, 2020 03:48 PM IST
Bloomberg | Posted by Niyati Singh
Chinese vaccine maker inks deal in Brazil for final testing
Beijing has mobilized its health authorities, drug regulators and research institutes to work around the clock with local companies to come up with the world’s first effective vaccine for Covid-19.
Updated on Jun 12, 2020 05:20 PM IST
Bloomberg | Bloomberg